Peptide Mapping: A Quality by Design (QbD) Approach

Applications | 2017 | Agilent TechnologiesInstrumentation
HPLC
Industries
Pharma & Biopharma, Proteomics
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Automated QbD-Based Method Development and Validation of Oxidative Degraded Atorvastatin
Quality‑by‑Design Approach to Stability Indicating Method Development for Linagliptin Drug Product
QbD Based Method Development on an Agilent 1290 Infinity UHPLC System Combined with a Seamless Method Transfer to HPLC Using Intelligent System Emulation Technology
Quality-by-Design-Based Method Development Using an Agilent 1290 Infinity II LC